Policy & Regulation
Stay informed about the latest cannabis regulation developments and changes with Business of Cannabis. Learn about new laws, policies and more.
Policy & Regulation · page 33
- CBD Market
Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost
THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms of gambling, alcohol and tobacco.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’
Akanda Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not seen since October.
- Adult-Use
Judge rejects New York challenge to suit that’s delaying cannabis store openings
NEW YORK LAWSUIT Judge rejects New York challenge to suit that’s delaying cannabis store openings MJ Biz Daily reports that a federal judge rejected New York’s effort to toss a lawsuit that’s been delaying the opening of recreational cannabis stores across the state, including in Brooklyn – continuing the wait for the issuance of 63…
- Hemp Industry
New year brings new laws, rules for cannabis businesses in the US
NEW LAWS New year brings new laws, rules for cannabis businesses in the US MJ Biz Daily explores how businesses in several states with legal cannabis markets, including California, Michigan, Oregon and Utah, are adapting to meet changing laws and regulations that could affect sales and how they run their operations.
- Policy & Regulation
New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower
AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical expert meeting’ on hexahydrocannabinol, better known as HHC.
- CBD Market
FDA’s inaction on CBD regulations means more cannabis questions for Congress
QUESTIONS FOR CONGRESS FDA’s inaction on CBD regulations means more cannabis questions for Congress The FDA’s announcement that it won’t regulate products containing CBD and will instead pass that buck to Congress means the preservation of the current, uneasy status quo for now, writes MJ Biz Daily.
- Policy & Regulation
European Round-Up: France’s CESE Calls For End To ‘Bitter Failure’ Of Cannabis Prohibition, Clever Leaves and Tilray Slash Portuguese Operations, & More From Czechia & Germany
FRANCE’s Economic, Social and Environmental Council (CESE) has released a ‘draft opinion’ calling for the legalisation of cannabis.
- Adult-Use
Minnesota House committee approves cannabis legalization bill
TO THE SENATE Minnesota House committee approves cannabis legalization bill Marijuana Moment reports that a third Minnesota House committee has approved a bill to legalize cannabis in the state, with another panel set to take it up on Thursday.
- Adult-Use
Germany Looks To Placate Brussels As Its Cannabis Plans Teeter
DELAYS in submitting its proposals to the European Commission and potential hold-ups once submitted could see Germany’s adult-use cannabis plans pushed back into 2025.
- CBD Market
First cannabis bill heads to the new 118th Congress
FIRST OUT THE GATE First cannabis bill heads to the new 118th Congress Seeking Alpha reports that a group of GOP lawmakers in the U.S.
- CBD Market
Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market
CANOPY GROWTH Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market The Motley Fool reports that Canopy’s sales in the second quarter of fiscal 2023 were reported as CAD$118 million, down 10% year over year.
- Medical
Research bill was the ‘most meaningful’ cannabis progress in 2022
2022 IN REVIEW Research bill was the ‘most meaningful’ cannabis progress in 2022 Benzinga speaks to industry experts to explore some of the most important tailwinds in 2022 that affected the industry, and that will lay strong foundations in the years to come.
